Sep / 2025

OncoDaily IO OncoDaily GI Hemostasis Today

20/02/2024

Feb 20, 2024 7:26 pm

Feb 20, 2024 7:22 pm

Feb 20, 2024 7:18 pm

Feb 20, 2024 7:04 pm

Feb 20, 2024 6:57 pm

Feb 20, 2024 6:51 pm

Feb 20, 2024 6:48 pm

Feb 20, 2024 6:41 pm

Feb 20, 2024 6:36 pm

Feb 20, 2024 3:58 pm

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29

20/02/2024

Drew Moghanaki: Hollywood’s nihilistic portrayal of cancer is potentially blind to the consequences on those of us in the trenches caring for people with this disease

Thomas Köhnke: Our work on ASXL1 mutations in clonal hematopoiesis and myeloid malignancies

Lisa Lacasse: No one should have to choose between affording food and paying for cancer care

Sumanta Pal: With my co-lead Rana McKay, so pleased to share with you the agenda for SoCalGU24

Penilla Gunther: A very interesting day in Brussels about ending financial discrimination against Cancer Survivors

Vivek Subbiah: Our editorial comments on the ASCO TAPUR study spearheaded by the amazing Richard Schilsky

The Pragmatica-Lung Study is considered a model for future cancer clinical trials – National Cancer Institute

Ofelia Cruz: In our weekly PCCB, Hospital Sant Joan de Déu Barcelona Oncology seminar, we had the best topic and presenter for the childhood cancer day

Emmy Fleuren: We are going to build the ‘Paediatric Preclinical Biobank’, with sarcomas as the flagship

Fabrice Barlesi: Gustave Roussy’s new building will form part of the largest cancer campus in France

Headlines

20/02/2024

Drew Moghanaki: Hollywood’s nihilistic portrayal of cancer is potentially blind to the consequences on those of us in the trenches caring for people with this disease

Thomas Köhnke: Our work on ASXL1 mutations in clonal hematopoiesis and myeloid malignancies

Lisa Lacasse: No one should have to choose between affording food and paying for cancer care

Sumanta Pal: With my co-lead Rana McKay, so pleased to share with you the agenda for SoCalGU24

Penilla Gunther: A very interesting day in Brussels about ending financial discrimination against Cancer Survivors

Vivek Subbiah: Our editorial comments on the ASCO TAPUR study spearheaded by the amazing Richard Schilsky

The Pragmatica-Lung Study is considered a model for future cancer clinical trials – National Cancer Institute

Ofelia Cruz: In our weekly PCCB, Hospital Sant Joan de Déu Barcelona Oncology seminar, we had the best topic and presenter for the childhood cancer day

Emmy Fleuren: We are going to build the ‘Paediatric Preclinical Biobank’, with sarcomas as the flagship

Fabrice Barlesi: Gustave Roussy’s new building will form part of the largest cancer campus in France

Headlines

OncoDaily

Oncology

cancer

fight against cancer

Global fight against cancer

cancer care

Breast Cancer

ASCO

Lung cancer

Cancer research

MD Anderson Cancer Center

cancer awareness

NSCLC

ESMO

immunotherapy

cancer treatment

Research

ASCO24

Headlines

colorectal cancer

Childhood Cancer

prostate cancer

AACR

clinical trials

FDA

Dana-Farber Cancer Institute

UICC

American Cancer Society

European Cancer Organisation

NCI

National Cancer Institute

healthcare

SIOP

ASCO25

chemotherapy

Vivek Subbiah

AI

American Society of Clinical Oncology

Paolo Tarantino

IASLC

WHO

Robert Orlowski

multiple myeloma

Memorial Sloan Kettering Cancer Center

Zainab Shinkafi-Bagudu

radiation oncology

Myeloma Paper of the Day

cervical cancer

Myeloma

patient care

European School of Oncology

Sitemap